Showing 301 - 320 of 590 results
Collaboration across the Tasman has enabled Australian and New Zealand researchers and scientists to shed light on a protein involved in diseases such as Parkinson’s disease, gastric cancer and melanoma.
Award recipients Dr Richard Garrett and Dr Nigel Lengkeek with Dr Tien Pham will deliver a Distinguished Lecture on 15 November at ANSTO.
Environmental scientist with a passion for fieldwork and a lifelong commitment to scientific excellence
The nandin Deep Technology Incubator at ANSTO’s Lucas Heights innovation precinct has welcomed two new members.
ANSTO has almost seventy years of experience in advancing an understanding of the management of spent nuclear fuel and delivering safe and reliable forms for radioactive waste.
ANSTO facilitating coordinated effort to find the nexus that leads to chronic kidney disease of unknown origin
In space, without the protection of the magnetosphere, the type and dose of radiation is considerably different to what is naturally experienced on earth. However, it is the secondary particles of lower energies created when galactic and cosmic radiation interacts with shielding that is of concern for astronauts.
In collaboration with the French National Institute of Health and Medical Research (INSERM) and the French International Space Agency (CNES), ANSTO scientists are undertaking research on the radiobiological effects of secondary particles that are created when radiation interacts with the shielding on the International Space Station.
$80.2 million in new funding to expand the research capabilities of the Australian Synchrotron.
Using the past to illuminate the future: Brothers collaborate on important science documentary for ABC TV
Dr Luiz Bortolan Neto, a structural materials engineer at ANSTO has received an Industry Partnership award for his significant contribution to defence science at the DMTC annual conference in Canberra, last week.
Peter Kabokov will continue work that will contribute to defence industry
ANSTO renewed its Memorandum of Understanding (MOU) with the Japan Proton Accelerator Research Complex (J-PARC) operated by the High Energy Accelerator Research Organisation (KEK) and Japan Atomic Energy Agency (JAEA). Now broadened to include their partner Comprehensive Research Organization for Science and Society (CROSS), the signing took place early in the year and a celebratory workshop was held late July.
ANSTO has contributed to research on a novel therapeutic option for combatting antimicrobial-resistant Gram-negative bacteria, known as superbugs.
Two Australian scientists have been appointed to assist with the development of a $500 million-dollar synchrotron facility in Mexico, the first and largest project of its kind.
A specialist in particle therapy treatment planning from the Mayo Clinic in the US, Professor Chris Beltran, recently visited ANSTO for an exchange for information.